SK Group bets on biotechnology as energy business slowsSep 8, 2000Korean conglomerate SK Group plans to spend $1 billion to build a biotechnology business, which it hopes will offset slow growth in its existing businesses.
e2-Capital branches into biotechnologyJun 26, 2000e2-Capital, co-founded by 34-year-old SJ Wong, is making waves in technology and telecoms. Now it''s targeting drugs.